Form 4: Cognex Director Exercises Options, Sells Shares

Cognex Corp. Director Robert Willett exercised stock options and subsequently sold a significant number of common shares under a Rule 10b5-1 trading plan.

Summary

• Director Robert Willett of Cognex Corp. executed a pre-arranged trading plan on February 12, 2026.
• This involved exercising non-qualified stock options for a total of 177,052 shares (173,296 shares at $38.39 and 3,756 shares at $39.44).
• Immediately following the exercise, all 177,052 shares were sold at a price of $58.3851 per share.
• Following these transactions, Willett's direct beneficial ownership of common stock is 0 shares.
• He retains indirect beneficial ownership of 15,804 shares through the Willett Parkhill Investment Trust.
• The director also continues to hold various non-qualified stock options for a total of 1,235,756 shares and 70,824 Restricted Stock Units.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While it's an insider sale, the pre-planned nature under Rule 10b5-1 mitigates concerns, and the director realized a significant profit while still retaining substantial equity exposure through other derivative holdings.

Positives

• The sale price of $58.3851 per share is significantly higher than the exercise prices of $38.39 and $39.44, indicating a profitable transaction for the director.
• The transactions were executed under a Rule 10b5-1 trading plan, which demonstrates pre-planned personal financial management rather than a reaction to new, non-public information.

Negatives

• The director sold all directly owned common stock acquired through the option exercise, which could be interpreted by some investors as a reduction in direct equity exposure, although it was part of a pre-arranged plan.

Future Outlook

NA

Management Comments

• These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Industry Context

StockSavvy.ai notes that insider selling, especially by a director, can sometimes be viewed with caution by the market as it might signal a lack of confidence. However, when executed under a pre-arranged Rule 10b5-1 plan, it typically indicates personal financial planning rather than a reaction to new, non-public information about the company's prospects. This reduces the potential for negative market interpretation compared to unplanned insider sales.

Corporate Governance

Related Party Transactions

• The reporting person is a trustee and beneficiary of Willett Parkhill Investment Trust dated August 2, 2010, which indirectly owns 15,804 shares of Common Stock. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Stakeholder Impact

• Shareholders: May observe the director's sale, but the Rule 10b5-1 plan suggests it's for personal financial planning rather than a negative signal about the company. The director still holds significant unexercised options and RSUs.
• Employees: No direct impact from this transaction.
• Customers/Suppliers/Creditors: No direct impact from this transaction.

Key Dates

Recommendation

The transaction is a pre-planned exercise and sale by a director, which is a routine event for personal financial management and not necessarily indicative of the company's future performance. While insider selling can sometimes be a bearish signal, the existence of a Rule 10b5-1 plan mitigates this concern. The director retains substantial derivative holdings, suggesting continued alignment with shareholder interests. Therefore, this single transaction does not warrant a change in investment thesis for Cognex Corp.

Keywords

Cognex, CGNX, Insider Trading, Form 4, Stock Options, Director Sale, Rule 10b5-1, Equity Transaction